Search bioRxiv⌕ Search

Biology subjects

Sajiki, Y.

Publications and source records attributed to Sajiki, Y..

2 recordsLinked to original sources

Functional heterogeneity and plasticity in naive CD8 T cells drive superior effector and memory responses

While significant progress has been made in defining subsets among antigen-experienced CD8 T cells, the heterogeneity of naive CD8 T cells remains poorly understood. Here, we identify naive CD8 T cell subsets with superior persistence and an enhanced capacity to generate effector and memory cells, leading to more effective protection. These high-quality naive CD8 T cells are marked by IL-18R, CD73, and CXCR3, and functionally less potent naive CD8 T cells can convert into these superior subsets. Their enhanced response to infections is driven by better survival of the progeny effector cells during the T cell expansion phase. This improved survival is mediated by increased Ly6C2 expression on effector cells derived from these high-quality naive cells. Collectively, our findings reveal functional heterogeneity and plasticity among naive CD8 T cells and uncover a mechanism by which high-quality naive subsets drive robust CD8 T cell responses, providing a previously unrecognized layer of immune regulation. SUMMARYOur study reveals functional heterogeneity and plasticity within naive CD8 T cells, identifying high-quality subsets that can emerge from less potent cells and drive superior immune responses through enhanced survival of effector progeny.

immunology↗

PBAE-PEG based lipid nanoparticles for lung cell-specific gene delivery

Delivery of modified mRNA encapsulated in lipid nanoparticles, exemplified by their successful use in COVID-19 vaccination, provides a framework for treating various genetic and acquired disorders. Herein, we developed PEGylated(PBAE-PEG) and non-PEGylated(PBAE) PBAE with lipids 4A3-SC8/DOPE/cholesterol/DOTAP to form lipid nanoparticles (LNPs) for mRNA delivery into different types of pulmonary cells in vivo. PBAE-PEG/LNP were highly active in transfecting HEK293T cells and air-liquid interfaced H441 cells in vitro. PBAE-PEG/LNP were used to express Cre-recombinase after administration to mice by intravenous injection, resulting in high transfection levels in pulmonary vascular endothelial cells. Intratracheal injection of both PBAE-PEG/LNP and PBAE/LNPs resulted in efficient and selective transfection of lung epithelial cells, identified by the expression of stabilized Cre-recombinase mRNA in club cells and alveolar type 2 cells. PBAE-PEG/LNP were most effective in transfecting alveolar type 2 cells after intratracheal injection, while PBAE/LNPs administered intratracheally were more effective in transfecting secretory airway cells. Cre-mediated recombination was specific to lung epithelial cells after intratracheal administration. Likewise, intravenous administration resulted in selective transfection of endothelial cells but not other pulmonary cell types, indicating their failure to cross the pulmonary endothelial-to-epithelial barrier. Moreover, 5-methoxyuridine modified mRNA was more efficient than unmodified mRNA in vivo but not in vitro.

bioengineering↗